SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $63,000 | -63.2% | 52,800 | +0.4% | 0.00% | – |
| Q4 2021 | $171,000 | -31.6% | 52,600 | -5.9% | 0.00% | – |
| Q3 2021 | $250,000 | -18.0% | 55,900 | 0.0% | 0.00% | – |
| Q2 2021 | $305,000 | +13.0% | 55,900 | +54.8% | 0.00% | – |
| Q1 2021 | $270,000 | -43.5% | 36,100 | -18.1% | 0.00% | – |
| Q4 2020 | $478,000 | +9.9% | 44,100 | -10.4% | 0.00% | – |
| Q3 2020 | $435,000 | -17.0% | 49,200 | 0.0% | 0.00% | – |
| Q2 2020 | $524,000 | +123.0% | 49,200 | +24.2% | 0.00% | – |
| Q1 2020 | $235,000 | +11.4% | 39,600 | +29.8% | 0.00% | – |
| Q4 2019 | $211,000 | -30.1% | 30,500 | +4.8% | 0.00% | – |
| Q3 2019 | $302,000 | +57.3% | 29,100 | +40.6% | 0.00% | – |
| Q2 2019 | $192,000 | +31.5% | 20,700 | +29.4% | 0.00% | – |
| Q1 2019 | $146,000 | +108.6% | 16,000 | +28.0% | 0.00% | – |
| Q4 2018 | $70,000 | -53.0% | 12,500 | 0.0% | 0.00% | – |
| Q3 2018 | $149,000 | +26.3% | 12,500 | +7.8% | 0.00% | – |
| Q2 2018 | $118,000 | – | 11,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,139,895 | $23,486,000 | 4.50% |
| Samsara BioCapital, LLC | 2,189,199 | $14,769,000 | 2.72% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $43,272,000 | 2.45% |
| Omega Fund Management, LLC | 1,562,500 | $11,688,000 | 1.11% |
| Flagship Pioneering Inc. | 2,938,494 | $21,980,000 | 0.35% |
| EcoR1 Capital, LLC | 1,000,000 | $7,480,000 | 0.33% |
| Altium Capital Management LP | 126,702 | $948,000 | 0.26% |
| Nikko Asset Management Americas, Inc. | 5,042,009 | $37,714,000 | 0.18% |
| Artal Group S.A. | 1,025,000 | $7,667,000 | 0.14% |
| Orbimed Advisors | 1,837,500 | $13,745,000 | 0.13% |